Your browser doesn't support javascript.
loading
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity.
Westcott, Peter M K; Muyas, Francesc; Hauck, Haley; Smith, Olivia C; Sacks, Nathan J; Ely, Zackery A; Jaeger, Alex M; Rideout, William M; Zhang, Daniel; Bhutkar, Arjun; Beytagh, Mary C; Canner, David A; Jaramillo, Grissel C; Bronson, Roderick T; Naranjo, Santiago; Jin, Abbey; Patten, J J; Cruz, Amanda M; Shanahan, Sean-Luc; Cortes-Ciriano, Isidro; Jacks, Tyler.
Afiliação
  • Westcott PMK; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. westcott@cshl.edu.
  • Muyas F; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. westcott@cshl.edu.
  • Hauck H; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
  • Smith OC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Sacks NJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Ely ZA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jaeger AM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Rideout WM; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Zhang D; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Bhutkar A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Beytagh MC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Canner DA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jaramillo GC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Bronson RT; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Naranjo S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jin A; Rodent Histopathology Core, Harvard Medical School, Boston, MA, USA.
  • Patten JJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Cruz AM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Shanahan SL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Cortes-Ciriano I; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jacks T; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Genet ; 55(10): 1686-1695, 2023 10.
Article em En | MEDLINE | ID: mdl-37709863

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Encefálicas / Neoplasias Colorretais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Encefálicas / Neoplasias Colorretais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos